Mayville Engineering Company, Inc.
NYSE:MECManufacturing - Metal Fabrication
+$1.19 today
- Market cap
- $333.55M
- Beta
- 1.29
- P/E (TTM)
- -43.5
- EPS (TTM)
- -$0.80
Volume 0.58M
Average 0.37M
MEC Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Mayville Engineering Company, Inc.NYSE: MEC
Gross Profit · Q1 FY2026 · quarter ended Mar 2026
Gross profit declines year over year
Q1 FY2026 gross profit of $7.83M fell 48.9% year over year, behind the -29.3% change in trailing-twelve-month gross profit. Sequentially, it fell 12.2% from the prior quarter. Over 3 fiscal years it compounded at -4.0% a year.
Context
- Gross profit amounted to 9.9% of revenue in FY2025, down 2.3 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -48.9% toward the trailing-twelve-month pace of -29.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 54.01M USD
- Year-over-year change
- -24.0%
- 4-year CAGR
- +1.3%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 54.01M | -24.0% |
| FY2024 | 2024-12-31 | 71.1M | +2.0% |
| FY2023 | 2023-12-31 | 69.7M | +14.1% |
| FY2022 | 2022-12-31 | 61.07M | +18.9% |
| FY2021 | 2021-12-31 | 51.38M | — |
Gross Profit vs competitors
How MEC compares with its peers on the latest reported figures
- MEC's LTM Mar 2026 gross profit of $46.31M is the 9th highest of the 10 companies compared; the peer median is $104.27M.
- Its year-over-year change of -29.3% is the 9th highest of 10, against a peer median of +1.1%.
- Gross profit amounts to 8.3% of revenue for MEC, versus a peer median of 28.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $488.6M | -22.3% | -13.2% | 15.5% | |
| LTM Mar 2026 | $410.9M | +10.4% | +3.5% | 18.1% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $118.88M | -22.9% | +3.5% | 70.2% |
| LTM Mar 2026 | $106.69M | +14.6% | -11.3% | 31.4% | |
| LTM Mar 2026 | $104.27M | -17.2% | +15.3% | 28.0% | |
| LTM Mar 2026 | $98.4M | +33.5% | — | 68.6% | |
| LTM Mar 2026 | $89.7M | +1.1% | -2.1% | 24.1% | |
| LTM Mar 2026 | $79.67M | +6.4% | -18.8% | 11.7% | |
| LTM Mar 2026 | $46.31M | -29.3% | -4.0% | 8.3% | |
| LTM Mar 2026 | $26.76M | -32.2% | +19.4% | 42.1% | |
| Peer median (excluding MEC) | $104.27M | +1.1% | +0.7% | 28.0% | |
Competitors are the stored peer set for MEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 454.83M | 539.39M | 588.43M | 581.6M | 546.49M |
| Cost of Revenue | 403.45M | 478.32M | 518.72M | 510.51M | 492.48M |
| Gross Profit | 51.38M | 61.07M | 69.7M | 71.1M | 54.01M |
| Gross Margin | 11.3% | 11.3% | 11.8% | 12.2% | 9.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 31.91M | 32.69M | 41.77M | 45.11M | 48.14M |
| Operating Expenses | 58.77M | 35.3M | 49.51M | 26.54M | 57.85M |
| Depreciation & Amortization | 31.78M | 29.31M | 35.08M | 37.59M | 41.29M |
| EBITDA | 24.39M | 55.09M | 55.06M | 82.14M | 37.44M |
| EBITDA Margin | 5.4% | 10.2% | 9.4% | 14.1% | 6.9% |
| Operating Income | (7.39M) | 25.77M | 20.19M | 44.55M | (3.84M) |
| Operating Margin | -1.6% | 4.8% | 3.4% | 7.7% | -0.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2M | 3.38M | 11.09M | 10.99M | 10.22M |
| Other Income / Expenses | (2M) | (3.38M) | (11.31M) | (10.99M) | (10.22M) |
| Income Before Tax | (9.39M) | 22.39M | 8.88M | 33.56M | (14.06M) |
| Pre-Tax Margin | -2.1% | 4.2% | 1.5% | 5.8% | -2.6% |
| Income Tax Expense | (1.94M) | 3.67M | 1.04M | 7.6M | (5.95M) |
| Net Income | (7.45M) | 18.73M | 7.84M | 25.97M | (8.11M) |
| Net Margin | -1.6% | 3.5% | 1.3% | 4.5% | -1.5% |
| EPS (Basic) | (0.37) | 0.92 | 0.38 | 1.26 | (0.40) |
| EPS (Diluted) | (0.37) | 0.92 | 0.38 | 1.24 | (0.40) |
| Weighted Avg Shares | 20.4M | 20.4M | 20.42M | 20.61M | 20.47M |
| Weighted Avg Shares (Diluted) | 20.83M | 20.68M | 20.7M | 20.97M | 20.47M |
Mayville Engineering Company, Inc.
NYSE:MEC
Intrinsic Alpha fair value
Locked
Current Price
$13.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.